NSC
37
-3
SIG
54
2
BIIB
38
-2
MAS
52
-2
MTCH
48
11
EW
53
-2
SBUX
32
-9
VMC
48
-2
SWKS
53
3
EXR
48
-3
CSX
44
-2
MCHP
43
6
JWN
61
5
ADSK
63
-5
AIZ
66
-2
AAL
59
-4
PBI
59
-7
EMR
64
-3
NRG
37
-2
KHC
22
2
NSC
37
-3
SIG
54
2
BIIB
38
-2
MAS
52
-2
MTCH
48
11
EW
53
-2
SBUX
32
-9
VMC
48
-2
SWKS
53
3
EXR
48
-3
CSX
44
-2
MCHP
43
6
JWN
61
5
ADSK
63
-5
AIZ
66
-2
AAL
59
-4
PBI
59
-7
EMR
64
-3
NRG
37
-2
KHC
22
2
Financhill
Back

Astellas Pharma Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Sell
44

ALPMF
Astellas Pharma

Last Price:
10.50
Seasonality Move:
0.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Astellas Pharma Price Quote

$10.50

Astellas Pharma Key Stats

Sell
44
Astellas Pharma (ALPMF) is a Sell
Day range:
$10.50 - $10.50
52-week range:
$9.13 - $12.74
Dividend yield:
4.67%
P/E ratio:
160.00
P/S ratio:
1.66
P/B ratio:
1.75%
Volume:
200
Avg. volume:
2.5K
1-year change:
-11.76%
Market cap:
$18.8B
Revenue:
$11.1B
EPS:
$0.06

How Much Does Astellas Pharma Make?

Is Astellas Pharma Growing As A Company?

  • What Is Astellas Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Astellas Pharma Stock Price Performance

  • Did Astellas Pharma Stock Go Up Last Month?
    Astellas Pharma share price went down by -5.36% last month
  • Did ALPMF's Share Price Rise Over The Last Year?
    ALPMF share price fell by -11.76% over the past 1 year

What Is Astellas Pharma 52-Week High & Low?

Astellas Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Astellas Pharma?

  • How Much Debt Does Astellas Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Astellas Pharma Have?
    Cash and short term investments quarterly total is $2.4B
  • What Is Astellas Pharma’s Book Value Per Share?
    Book value per share is 5.88

Is Astellas Pharma Cash Flow Positive?

  • What Is ALPMF Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.2B
  • What Is Astellas Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.3B
  • What Is Astellas Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.9B

Astellas Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ALPMF return on invested capital is 0.66%
  • What Is Astellas Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is 0.47%
  • What Is ALPMF Return On Equity?
    ROE is a measure of profitability and is 0.97%

Astellas Pharma Earnings Date & Stock Price

Astellas Pharma Competitors

  • Who Are Astellas Pharma's Competitors?
    Below is a list of companies who compete with Astellas Pharma or are related in some way:
    • Pfizer Inc (PFE)
    • PeptiDream Inc (PPTDF)
    • Nxera Pharma Co Ltd (SOLTF)
    • Takeda Pharmaceutical Co Ltd (TAK)

Astellas Pharma Dividend Yield

Astellas Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0.07% 0%
Revenue: 11.06% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ALPMF shares are owned by institutional investors?
    823.4M ALPMF shares are owned by institutional investors
  • How many ALPMF shares are owned by insiders?
    0 ALPMF shares are owned by insiders